Skip to main content

AusPAR: Certolizumab pegol

Australian Public Assessment Report
Device/Product Name
Cimzia
Active ingredients
Certolizumab pegol
AusPAR Date
Published
Submission Number
PM-2017-04943-1-1
Submission Type
Major variation; extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site